Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CStone Pharmaceuticals Announces Updated Results from Two Studies of Its Anti-PD-L1 Monoclonal Antibody Sugemalimab (CS1001) At 2020 CSCO Annual Meeting 2020-09-25 15:28
CStone Announces Preliminary Results from a Bridging Study of Avapritinib in Chinese Patients with Unresectable or Metastatic Gastrointestinal Stromal Tumors at the 2020 CSCO Annual Meeting 2020-09-25 14:53
GenScript ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program 2020-09-24 22:00
New Centre for Medicines Research Report from Clarivate Indicates Drug Development Timelines are Shortest Since 2013 2020-09-24 16:15
Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases 2020-09-24 08:00
ImmVira Announces US$10 million Strategic Series B Plus Financing with SIIC Capital 2020-09-24 00:09
Insilico releases Pandomics, AI-powered platform for Novel Therapeutic Target Discovery 2020-09-23 22:00
Genor Biopharma Announces Proposed Listing on the Main Board of SEHK 2020-09-23 12:00
Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial 2020-09-22 20:53
New Study Suggests GlycoMark® May Identify Highest Risk Patients with Prediabetes 2020-09-22 19:00
TCM Lianhua Qingwen Capsule approved for registration in Mauritius 2020-09-22 15:21
Harbour BioMed Announces Two China NMPA Clearances for Clinical Trials for Phase I & Combination Therapy of Next Generation Anti-CTLA-4 Antibody for Treatment of Solid Tumors 2020-09-21 20:12
I-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma 2020-09-21 20:00
PharmAbcine expands partnership with Samsung Biologics for PMC-403 2020-09-21 20:00
Hyde Engineering + Consulting Announces New VP of Global Engineering 2020-09-21 11:30
Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain 2020-09-21 10:35
Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020 2020-09-21 08:00
Innovent and Lilly Release Biomarker Results of TYVYT® (Sintilimab Injection) in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020 2020-09-21 08:00
Preparation products of Yiling Pharma approved by FDA for launch in the US market 2020-09-19 19:14
BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine 2020-09-18 15:00
1 279 280 281 282 283 412